Article Sidebar
Published:
Nov 24, 2016Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Liver transplantation for viral hepatitis - which patients will benefit?
Abstract
Liver transplantation constitutes a significant part of the hepatologist's armamentarium and has become the treatment of choice for most patients with chronic end-stage liver disease. The results continue to improve and many centres are now able to achieve 1-year survival figures in excess of 90% in selected patients. The surgical techiques involved in liver transplantation and the immunosuppressive protocols used postoperatively have been standardised. In contrast, the indications for and contraindications to liver transplantation continue to be modified. Large numbers of patients have undergone liver transplantation in recent years and analyses of large series of patients have made it possible to determine more accurately the outcome of liver transplantation in specific hepatic disease processes. As a result, subsets of patients who are more likely to survive long term have been identified. This is particularly true of patients with viral hepatitis.
